PHG
Profit gets a boost
Philips came out of the second quarter looking a little better than the market may have expected. The Dutch healthcare and consumer-tech giant said profit climbed, helped by a U.S. tariff refund and modestly higher net sales. So yes, the top line had a bit of help from the policy gods.
But the order book told a different story
Comparable order intake fell 1%, and that matters because orders are the coffee bean of the future revenue machine. If they’re soft, the next few quarters can get a little less exciting, even when today’s numbers look fine.
Management is still sounding confident
The brighter part of the update: Philips lifted its FY26 adjusted EBITA outlook and reaffirmed its sales forecast. Translation for investors: management thinks margins can keep improving, and it doesn’t see a sales faceplant coming.
- Profit got a lift from a tariff refund
- Sales were slightly higher
- Orders slipped 1%
- Full-year adjusted EBITA guidance moved up
- Sales guidance stayed on track
Big picture: this is a classic earnings-day split screen — better profitability now, softer demand signals underneath. If you own the stock, the next question is whether Philips can turn those order trends back up before investors start getting twitchy.